PHX Stock Overview
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PharmX Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.031 |
| 52 Week High | AU$0.049 |
| 52 Week Low | AU$0.012 |
| Beta | 1.4 |
| 1 Month Change | -3.13% |
| 3 Month Change | -18.42% |
| 1 Year Change | -22.50% |
| 3 Year Change | -65.17% |
| 5 Year Change | 19.23% |
| Change since IPO | -71.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHX | AU Software | AU Market | |
|---|---|---|---|
| 7D | -3.1% | 3.0% | 1.6% |
| 1Y | -22.5% | 38.3% | 7.9% |
Return vs Industry: PHX underperformed the Australian Software industry which returned 38.3% over the past year.
Return vs Market: PHX underperformed the Australian Market which returned 7.9% over the past year.
Price Volatility
| PHX volatility | |
|---|---|
| PHX Average Weekly Movement | n/a |
| Software Industry Average Movement | 8.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: PHX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | n/a | Tom Culver | pharmx.com.au |
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. The company’s network connects retail pharmacy and suppliers in Australia and New Zealand. It operates PharmX, an electronic pharmacy ordering gateway; and PharmXchange, a digital sales and marketing platform integrated with PharmX for pharmacies and their suppliers.
PharmX Technologies Limited Fundamentals Summary
| PHX fundamental statistics | |
|---|---|
| Market cap | AU$17.96m |
| Earnings (TTM) | AU$263.00k |
| Revenue (TTM) | AU$6.28m |
68.3x
P/E Ratio2.9x
P/S RatioIs PHX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHX income statement (TTM) | |
|---|---|
| Revenue | AU$6.28m |
| Cost of Revenue | AU$3.98m |
| Gross Profit | AU$2.30m |
| Other Expenses | AU$2.04m |
| Earnings | AU$263.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00044 |
| Gross Margin | 36.61% |
| Net Profit Margin | 4.19% |
| Debt/Equity Ratio | 0% |
How did PHX perform over the long term?
See historical performance and comparison